PT72774A - Process for preparing stable concentrated solutions of cisplatin - Google Patents

Process for preparing stable concentrated solutions of cisplatin

Info

Publication number
PT72774A
PT72774A PT72774A PT7277481A PT72774A PT 72774 A PT72774 A PT 72774A PT 72774 A PT72774 A PT 72774A PT 7277481 A PT7277481 A PT 7277481A PT 72774 A PT72774 A PT 72774A
Authority
PT
Portugal
Prior art keywords
cisplatin
concentrated solutions
preparing stable
stable concentrated
preparing
Prior art date
Application number
PT72774A
Other languages
Portuguese (pt)
Other versions
PT72774B (en
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of PT72774A publication Critical patent/PT72774A/en
Publication of PT72774B publication Critical patent/PT72774B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT72774A 1980-03-31 1981-03-30 Process for preparing stable concentrated solutions of cis- platin PT72774B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
PT72774A true PT72774A (en) 1981-04-01
PT72774B PT72774B (en) 1982-11-16

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72774A PT72774B (en) 1980-03-31 1981-03-30 Process for preparing stable concentrated solutions of cis- platin

Country Status (30)

Country Link
JP (1) JPS56152415A (en)
KR (1) KR860000841B1 (en)
AR (1) AR225500A1 (en)
AT (1) AT370996B (en)
AU (1) AU541056B2 (en)
BE (1) BE888209A (en)
CA (1) CA1162479A (en)
CH (1) CH647481A5 (en)
CS (1) CS246051B2 (en)
DD (1) DD157762A5 (en)
DE (1) DE3112272A1 (en)
DK (1) DK158564C (en)
ES (1) ES500869A0 (en)
FI (1) FI70670C (en)
FR (1) FR2480605A1 (en)
GB (1) GB2074028B (en)
GR (1) GR72769B (en)
HU (1) HU183379B (en)
IE (1) IE51070B1 (en)
IL (1) IL62517A (en)
IT (1) IT1170838B (en)
LU (1) LU83270A1 (en)
NL (1) NL8101531A (en)
NO (1) NO156675C (en)
NZ (1) NZ196519A (en)
PH (1) PH17152A (en)
PT (1) PT72774B (en)
SE (1) SE455045B (en)
SU (1) SU1056893A3 (en)
ZA (1) ZA812084B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (en) * 1982-09-23 1987-01-21 Erba Farmitalia PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATIN AND METHOD FOR THEIR OBTAINMENT
NL8303657A (en) * 1983-10-24 1985-05-17 Pharmachemie Bv SOLUTION, STABLE, AQUEOUS, AQUEOUS, CONTAINING SOLUTION OF CISPLATINE, AND METHOD OF PREPARING THEREOF.
FI895340A0 (en) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co HYPERTONISK CISPLATIN-LOESNING.
ATE252372T1 (en) * 1996-08-23 2003-11-15 Sequus Pharm Inc LIPOSOMES CONTAINING CISPLATIN
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (en) 2004-03-26 2010-04-07 オンキヨー株式会社 Switching amplifier
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (en) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
IT8148090A0 (en) 1981-03-24
GB2074028B (en) 1983-09-21
SE455045B (en) 1988-06-20
ZA812084B (en) 1982-04-28
JPS56152415A (en) 1981-11-26
NL8101531A (en) 1981-10-16
ES8206545A1 (en) 1982-08-16
ATA150481A (en) 1982-10-15
NO811081L (en) 1981-10-01
JPS6360008B2 (en) 1988-11-22
IL62517A (en) 1984-01-31
IE810715L (en) 1981-09-30
FI70670B (en) 1986-06-26
FR2480605A1 (en) 1981-10-23
CA1162479A (en) 1984-02-21
HU183379B (en) 1984-04-28
AU6816681A (en) 1981-10-08
DK144281A (en) 1981-10-01
ES500869A0 (en) 1982-08-16
NO156675C (en) 1987-11-04
DE3112272C2 (en) 1990-09-27
FR2480605B1 (en) 1984-05-11
KR860000841B1 (en) 1986-07-09
CS246051B2 (en) 1986-10-16
CH647481A5 (en) 1985-01-31
FI810934L (en) 1981-10-01
NZ196519A (en) 1983-06-17
KR830004849A (en) 1983-07-20
BE888209A (en) 1981-09-30
DE3112272A1 (en) 1982-04-29
PT72774B (en) 1982-11-16
DD157762A5 (en) 1982-12-08
SU1056893A3 (en) 1983-11-23
AT370996B (en) 1983-05-25
GB2074028A (en) 1981-10-28
FI70670C (en) 1986-10-06
NO156675B (en) 1987-07-27
IE51070B1 (en) 1986-09-17
AR225500A1 (en) 1982-03-31
DK158564C (en) 1990-11-05
AU541056B2 (en) 1984-12-13
GR72769B (en) 1983-12-02
IL62517A0 (en) 1981-05-20
LU83270A1 (en) 1981-10-29
IT1170838B (en) 1987-06-03
SE8101990L (en) 1981-11-13
PH17152A (en) 1984-06-13
DK158564B (en) 1990-06-11

Similar Documents

Publication Publication Date Title
PT69685A (en) Process for preparing herbicids containing pirazolic etherderivatives
PT76195A (en) Process for preparing stabilized solutions
PT73957B (en) Process for preparing piperazinylbenzoheterocyclic compounds
PT73658B (en) Process for preparing ammoniomethyl compounds
DE3368056D1 (en) Process for preparing l-ascorbic acid
GB2082172B (en) Process for preparing n-alkyl-alkylenediamines
SU1192596A3 (en) Method of producing stable solution of cisplatin
PT72774A (en) Process for preparing stable concentrated solutions of cisplatin
DE3378049D1 (en) Process for preparing ascorbic acid
DE3163672D1 (en) Process for preparing 1-amino-alkane-1,1-diphosphonic acid
RO82537B (en) Process for preparing diaceton-cetugulonic acid
PT72840B (en) Process for preparing phenyl-quinolizidines
DE3160358D1 (en) Process for preparing aryl-phosphonyl compounds
DE3161061D1 (en) Process for preparing arylacetaldehydes
PT74684B (en) Process for preparing stable concentrated solutions of cisplatin
DE3160245D1 (en) Process for preparing n-methyl-carbamate of methylthioacetal-doxime
DE3161108D1 (en) Process for preparing cyclopentenolones
YU135081A (en) Process for producing indolacetic acid derivatives
GB2068962B (en) Process for preparing valproic acid
DE3166274D1 (en) Process for preparing v-triazole compounds
DE3165126D1 (en) Process for preparing cyclopentenolones
PT74164B (en) Process for preparing 7-beta-amino-3-cephem-4-carboxylic acid compound
YU214180A (en) Process for preparing the dimethoxymethylester of cyanoimidodithiocarbonic acid
DE3168346D1 (en) Process for preparing n-cyanolactames
SI8110026A8 (en) PROCESS FOR PREPARING OF IFN-alfa-type POLIPEPTIDES.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940517